Résultats de la recherche - 7 results
Risks related to a possible reduction of the waiting period for dogs after rabies antibody titration to 30 days compared with 90 days of the current EU legislative regime.
where rabies has long been a focus for eradication, to protect human and animal health. Health Topics: Rabies Rage Rabiës Service: Maladies virales Virale ziekten Viral diseases Manuscript versions: ...
Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG(®)): a global review.
into the environment, and has been tested for thermostability under a range of laboratory and field conditions. Safety of V- RG has been evaluated in over 50 vertebrate species, including non-human ...
Impact of caspase-1/11,-3,-7, or IL-1/IL-18 deficiency on rabies virus-induced macrophage cell death and onset of disease.
Cell Death Discov, Volume 3, p.17012 (2017) Abstract: Rabies virus is a highly neurovirulent RNA virus, which causes about 59000 deaths in humans each year. Previously, we described macrophage ...
Epidemiology, Impact and Control of Rabies in Nepal: A Systematic Review
human rabies were obtained from the relevant Nepalese government agencies. Finally, we surveyed the archives of a Nepalese daily to obtain qualitative information on rabies in Nepal. Findings So far, only ...
Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection.
8, p.e0004902 (2016) Keywords: Animals Antibodies, Neutralizing Antibodies, Viral Cell Line Disease Models, Animal Female Half-Life Humans mice Neutralization Tests Post-Exposure Prophylaxis Rabies ...
Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice.
highest available dose of human anti-rabies immunoglobulins (65 mg, 111 IU, 1 ml) only prolonged survival by 2 days, without rescue. Overall, the therapeutic benefit seemed well correlated with the time of ...
Antibody response in Dutch marines to a single intramuscular rabies booster immunization 1-2.5 years after an intradermal pre-exposure schedule: An observational study.
Infect Dis, Volume 38 (2020) Keywords: Antibodies, Viral Antibody Formation Follow-Up Studies Humans Immunization Schedule Immunization, Secondary Immunogenicity, Vaccine Injections, Intradermal ...